KerryAnneRogersMD

PubMed

• Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
  Barr, P. M., Barr, P. M., Barr, P. M., Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Na...> ;Blood. 2024 Apr 18
• Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
  Adam S Kittai, Ying Hang, Seema A Bhat, Abi Clark, Michael Grever, Joanna M Rhodes, Melyssa Roberts, Kerry A Rogers, Anna Teschemaker, Maria Munoz-Sagastibelza, Jennif...> ;American Journal of Hematology. 2024 Apr 1
• Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
  Adam S Kittai, David Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carr...> ;Journal of Clinical Oncology. 2024 Mar 29
• Pairing obinutuzumab with venetoclax in relapsed CLL.
  Philip A Thompson, Kerry A Rogers> ;Leukemia & Lymphoma. 2024 Mar 18
• Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia.
  Avenarius, M., Huang, Y., Miller, C., Kittai, A., Bhat, S., Rogers, K., Grever, M., Woyach, J.> ;Leukemia. 2024 Mar 1
• Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.
  Samantha M Teierle, Ying Huang, Adam S Kittai, Seema A Bhat, Michael Grever, Kerry A Rogers, Weiqiang Zhao, Daniel Jones, John C Byrd, Matthew R Avenarius, Nyla A Heer...> ;Blood Advances. 2023 Dec 12
• Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2.
  Kaitlin Annunzio, Michael Ozga, Ying Huang, Mirela Anghelina, Seema A Bhat, James S Blachly, Michael R Grever, Gerard Lozanski, Jasmine Neal, Polina Shindiapina, Kerry...> ;Ejhaem. 2023 Nov 1
• 5 citations
  Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia:State-of-the-Art Review.
  Kola-Kehinde, O., Cooper Quartermaine, Sanam M Ghazi, Aneeq Yasin, Farrukh T Awan, Michael Fradley, Tracy Wiczer, Sujay Kalathoor, Mussammat Ferdousi, Satyam Krishan, ...> ;JACC. Cardiooncology. 2023 Oct 1
• 4 citations
  Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia.
  Chaitra Ujjani, Ted A Gooley, Stephen E Spurgeon, Deborah M Stephens, Catherine Lai, Catherine M Broome, Susan O'Brien, Haiying Zhu, Kerry J Laing, Allison M Winter, G...> ;Blood Advances. 2023 Sep 12
• Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma.
  Xiaoxiao Lu, Bruno Emond, Zaina P Qureshi, Linda H Wu, Shaun P Forbes, Annalise Hilts, Stephanie Liu, Marie-Hélène Lafeuille, Patrick Lefebvre, Qing Huang, Kerry A Rogers> ;Current Medical Research and Opinion. 2023 Sep 1
• 4 citations
  Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019.
  Adam S Kittai, Ying Huang, Seema A Bhat, Electra D Paskett, Kerry A Rogers, Jacqueline C Barrientos, James L Fisher, Jennifer A Woyach> ;Blood Advances. 2023 Jun 13
• A CAPTIVATEing Analysis for Higher-Risk CLL.
  Kerry A Rogers> ;Clinical Cancer Research. 2023 Jul 14
• Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy.
  Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C Byrd, Michael R Grever, Kerry A Rogers, J...> ;Leukemia. 2023 Jul 1
• Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
  Matthew R Avenarius, Ying Huang, Jonathan Hyak, John C Byrd, Seema A Bhat, Michael Grever, Adam S Kittai, Kerry A Rogers, Dan Jones, Weiqiang Zhao, Nyla A Heerema, Lyn...> ;Hematological Oncology. 2023 Oct 1
• 1 citations
  Evaluation of bleeding events in patients receiving acalabrutinib therapy.
  Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C Byrd, Michael R Grever, Kerry A Rogers, J...> ;Leukemia. 2023 Jul 1
• 1 citations
  Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis.
  Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, Jasmine Neal, James S Blachly, Kerry A Rogers, Gerard Lozanski, Christopher C Oakes, Seema A Bhat, Clive S Zent, ...> ;American Journal of Hematology. 2023 May 1
• 4 citations
  Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
  Benjamin Buck, Aaron P Chum, Mitkumar Patel, Rebecca Carter, Haseeb Nawaz, Vedat Yildiz, Patrick Ruz, Tracy Wiczer, Kerry A Rogers, Farrukh T Awan, Seema Bhat, Avirup ...> ;JAMA Oncology. 2023 Apr 1
• 3 citations
  Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
  Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timoth...> ;Blood Cancer Journal. 2022 Dec 13
• 22 citations
  Ventricular arrhythmias and sudden death events following acalabrutinib initiation.
  Seema A Bhat, John Gambril, Leylah Azali, Sunnia T Chen, Lindsay Rosen, Marilly Palettas, Tracy E Wiczer, Sujay Kalathoor, Qiuhong Zhao, Kerry A Rogers, Adam Kittai, M...> ;Blood. 2022 Nov 17
• 4 citations
  Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemia.
  Elizabeth M Muhowski, Janani Ravikrishnan, Britten Gordon, Lianbo Yu, Shrilekha Misra, Brandi Walker, Sudharshan Eathiraj, Deepa Sampath, Kerry A Rogers, John C Byrd, ...> ;Journal of Hematology & Oncology. 2022 Nov 15
• 6 citations
  Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy.
  Chia Sharpe, J Rachel Lance, Janani Ravikrishnan, Kevan Zapolnik, Xiaokui Mo, Jennifer A Woyach, Deepa Sampath, Adam S Kittai, Sumithira Vasu, Seema Bhat, Kerry A Roge...> ;Blood Advances. 2022 Oct 25
• 6 citations
  Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
  Adam S Kittai, Ying Huang, Kyle A Beckwith, Seema A Bhat, David A Bond, John C Byrd, Daniel Goldstein, Michael R Grever, Cecelia Miller, Kerry A Rogers, Jennifer A Woy...> ;American Journal of Hematology. 2023 Jan 1
• Corrigendum to "Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy...
  Mirela Anghelina, Michelle J Naughton, Qiuhong Zhao, Amy S Ruppert, Jasmine Neal, Kerry A Rogers, James S Blachly, Gerard Lozanski, Seema A Bhat, Eric Kraut, Narendran...> ;Leukemia Research. 2022 Oct 1
• 2 citations
  Differential regulation of CTLA4 expression through BTK-dependent and independent mechanisms in CLL.
  Jessica Nunes, Xiaokui Mo, Kerry A Rogers, Jennifer A Woyach, John C Byrd, Natarajan Muthusamy, Yano, M.> ;Blood Advances. 2022 Sep 27
• 5 citations
  Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.
  Jonathan M Hyak, Ying Huang, Kerry A Rogers, Seema A Bhat, Michael R Grever, John C Byrd, Adam S Kittai, Dan Jones, Cecelia R Miller, Jennifer A Woyach> ;Blood Advances. 2022 Sep 13
• Join now to see all

Abstracts/Posters

• Restoring Functional Deficits in Older Adults with Hematologic Malignancy
  Kerry A. Rogers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Ibrutinib Treatment in CLL Patients Improves T Cell Function and Blinatumomab Redirected Cytotoxicity
  Kerry A. Rogers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Selinexor Combined with Ibrutinib Demonstrates Tolerability and Efficacy in Advanced B-Cell Malignancies: A Phase I Study
  Kerry A Rogers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Rapid Dose Escalation of Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with B-Cell Receptor Inhibitor Therapy
  Kerry A. Rogers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• LC-Facseq: A Novel Method for Detecting Rare Resistant Clones in Leukemia
  Kerry A. Rogers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• A Multicenter Study of Ibrutinib Resistance Development and Intervention with Venetoclax in Patients with Chronic Lymphocytic Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicent... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Phase 2 study of acalabrutinib in ibrutinib (IBR)-intolerant patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). 
  2019 ASCO Annual Meeting - 6/1/2019
• Infection at the Time of Initial Therapy for Hairy Cell Leukemia Is Associated with Inferior Time to Next Treatment 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Mutations in the Ras Pathway in Pre-Treatment Chronic Lymphocytic Leukemia Are Associated with VH1-69: Linking B-Cell Receptor Stereotypy to Downstream Signaling Events 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Chronic Lymphocytic Leukemia (CLL) Transformed into Hodgkin Lymphoma (HL): Clinical Characteristics and Outcomes from a Large Multi-Center Collaboration 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Change in tumor lysis syndrome risk after lead-in treatment in a phase 1b/2 study of obinutuzumab, ibrutinib, and venetoclax for chronic lymphocytic leukemia. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Join now to see all